Derivatives of 4-amino-pyridine as selective thrombin inhibitors

被引：29

作者：

vonderSaal, W ^{[1
]}

Kucznierz, R ^{[1
]}

Leinert, H ^{[1
]}

Engh, RA ^{[1
]}

机构：

[1] MAX PLANCK INST BIOCHEM, D-82152 MARTINSRIED, GERMANY

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1997年 / 7卷 / 10期

关键词：

D O I：

10.1016/S0960-894X(97)00210-2

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

During screening for novel thrombin inhibitors it was discovered that the il-aminopyridine derivative 1 inhibits human alpha-thrombin competitively and selectively. The 4-aminopyridine moiety itself is most likely the major determinant of the selectivity due to the increased hydrophobicity of the S1 pocket in thrombin compared to trypsin and plasmin. Optimization led to the selective thrombin inhibitor 14 with an inhibition constant, Ki of 70 nM. (C) 1997 Elsevier Science Ltd.

引用

页码：1283 / 1288

页数：6

共 22 条

[1] BANNER DW, 1991, J BIOL CHEM, V266, P20085
[2] THE REFINED 1.9 A CRYSTAL-STRUCTURE OF HUMAN ALPHA-THROMBIN - INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT
BODE, W
MAYR, I
BAUMANN, U
HUBER, R
STONE, SR
HOFSTEENGE, J
[J]. EMBO JOURNAL, 1989, 8 (11) : 3467 - 3475
[3] GEOMETRY OF BINDING OF THE BENZAMIDINE-BASED AND ARGININE-BASED INHIBITORS N-ALPHA-(2-NAPHTHYL-SULFONYL-GLYCYL)-DL-PARA-AMIDINOPHENYLALANYL-PIPERIDINE (NAPAP) AND (2R,4R)-4-METHYL-1-[N-ALPHA-(3-METHYL-1,2,3,4-TETRAHYDRO-8-QUINOLINESULPHONYL)-L-ARGINYL]-2-PIPERIDINE CARBOXYLIC-ACID (MQPA) TO HUMAN ALPHA-THROMBIN - X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE NAPAP-TRYPSIN COMPLEX AND MODELING OF NAPAP-THROMBIN AND MQPA-THROMBIN
BODE, W
TURK, D
STURZEBECHER, J
[J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 193 (01): : 175 - 182
[4] Bohm HJ, 1996, ANGEW CHEM INT EDIT, V35, P2589
[5] BOHM HJ, 1996, ANGEW CHEM, V108, P2750
[6] REFINED 2.3-ANGSTROM X-RAY CRYSTAL-STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA - A STARTING POINT FOR IMPROVING ANTITHROMBOTICS
BRANDSTETTER, H
TURK, D
HOEFFKEN, HW
GROSSE, D
STURZEBECHER, J
MARTIN, PD
EDWARDS, BFP
BODE, W
[J]. JOURNAL OF MOLECULAR BIOLOGY, 1992, 226 (04) : 1085 - 1099
[7] Synthesis of conformationally-restricted boropeptide thrombin inhibitors
Cacciola, J
Fevig, JM
Alexander, RS
Brittelli, DR
Kettner, CA
Knabb, RM
Weber, PC
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (03) : 301 - 306
[8] THROMBIN ACTIVE-SITE INHIBITORS
DAS, J
KIMBALL, SD
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1995, 3 (08) : 999 - 1007
[9] UV, H-1 AND C-13 NMR-SPECTRA, AND AM1 STUDIES OF PROTONATION OF AMINOPYRIDINES
DEGASZAFRAN, Z
KANIA, A
NOWAKWYDRA, B
SZAFRAN, M
[J]. JOURNAL OF MOLECULAR STRUCTURE, 1994, 322 : 223 - 232
[10] Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: Implications for drug design
Engh, RA
Brandstetter, H
Sucher, G
Eichinger, A
Baumann, U
Bode, W
Huber, R
Poll, T
Rudolph, R
vonderSaal, W
[J]. STRUCTURE, 1996, 4 (11) : 1353 - 1362

← 1 2 3 →